Advertisement

The Latest

Recent research reveals overuse of healthcare services in the United States, according to a study published in the Archives of Internal Medicine.

Genzyme, a company producing therapies for rare diseases, received FDA clearance for its manufacturing plant in Framingham, Mass., for the production of Fabrazyme, an enxyme replacement therapy for Fabry disease, according to a news release.

Advertisement